Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

Mylan Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?

MYLAN PHARMS INC has one hundred and eight approved drugs.

Summary for Mylan Pharms Inc

US Patents:	0
Tradenames:	94
Ingredients:	93
NDAs:	108

Drugs and US Patents for Mylan Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Pharms Inc	VALACYCLOVIR HYDROCHLORIDE	valacyclovir hydrochloride	TABLET;ORAL	078518-001	May 24, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	ESCITALOPRAM OXALATE	escitalopram oxalate	CAPSULE;ORAL	077660-002	Jul 31, 2007		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	PAROXETINE HYDROCHLORIDE	paroxetine hydrochloride	TABLET;ORAL	075716-001	Mar 8, 2004		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	CLINDAMYCIN HYDROCHLORIDE	clindamycin hydrochloride	CAPSULE;ORAL	091225-002	May 31, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	ESCITALOPRAM OXALATE	escitalopram oxalate	CAPSULE;ORAL	077660-001	Jul 31, 2007		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mylan Pharms Inc	DIDANOSINE	didanosine	CAPSULE, DELAYED REL PELLETS;ORAL	090788-004	Apr 8, 2010		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Mylan Pharms Inc

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	4,971,800	See Plans and Pricing
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	5,045,317	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Johnson and Johnson

Express Scripts

Moodys

AstraZeneca

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.